# Bioequivalence Study Between "Dong-A Atorvastatin Tab" and "Lipitor Tab"

> **NCT04325009** · PHASE1 · UNKNOWN · sponsor: **Dong-A ST Co., Ltd.** · enrollment: 56 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Lipitor 80mg Tab → Dong-A Atorvastatin 80mg Tab
- **DRUG:** Dong-A Atorvastatin 80mg Tab → Lipitor 80mg Tab

## Key facts

- **NCT ID:** NCT04325009
- **Lead sponsor:** Dong-A ST Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-30
- **Primary completion:** 2020-05
- **Final completion:** 2020-08
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2020-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04325009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04325009, "Bioequivalence Study Between "Dong-A Atorvastatin Tab" and "Lipitor Tab"". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04325009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*